Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study

Status Completed

Clinical Trial Summary

This prospective randomized controlled trial will be conducted to investigate Clareon intraocular lens (IOL) stability in vitrectomy patients. The investigator plans to target the patients undergoing cataract surgery. A randomized study will be conducted with 2 arms, one with Clareon IOL versus a second arm using the Tecnis 1 In this non-inferiority study, the investigator will compare Clareon IOL from Alcon with the existing Tecnis 1 IOL from Precision Lens which is the commonly used intraocular lens in combined vitrectomy cases in Hong Kong.

Clinical Trial Description

All patients will undergo standard phacoemulsification cataract extraction with Clareon IOL or Tecnis 1 IOL by an experienced cataract surgeon. Followed by vitrectomy to treat either, epiretinal membrane or vitreous hemorrhage. All patients returned for follow-up visits at 1 week, 1 month, and 6 months after surgery for ophthalmic assessments including: - Visual acuity measured by Early Treatment of Diabetic Retinopathy Study (ETDRS) chart - Refraction - Axial movement and tilt measured by Pentacam (OCULUS Optikgeräte GmbH, Germany) using the Sasaki method. The Scheimpflug image of the horizontal cross-section and the vertical cross-section of the IOL will be selected for measurement. Central ACD will be measured as the distance between the central corneal posterior endothelium to the anterior surface of IOL. The subtraction in ACD between two visits indicated forward or backward axial movement of the IOL. - Decentration will be measured from the center of the IOL anterior surface to the pupillary axis, which will be perpendicular to the line between the two anterior chamber angles and through the midpoint of the line. - Tilt will be measured as the angle between the IOL axis and the perpendicular visual axis. - Any surgical complications and post-op complications will be documented. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06383754
Study type	Interventional
Source	The University of Hong Kong
Contact
Status	Completed
Phase	N/A
Start date	June 7, 2021
Completion date	March 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03332758` - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Active, not recruiting	`NCT04130841` - Effects of Internal Limiting Membrane Peeling on Visual Function in Epiretinal Membrane Surgery	N/A
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Terminated	`NCT01532765` - Randomized Trial Comparing Epiretinal Membrane Surgery With and Without Internal Limiting Membrane Removal	N/A
Completed	`NCT01474655` - Retinal Layers and Visual Rehabilitation After Epiretinal Membrane Removal	N/A
Active, not recruiting	`NCT04120311` - Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole	Phase 1
Completed	`NCT04445142` - Fovea ERM After Fovea-sparing ILM Peeling
Recruiting	`NCT01701518` - A Pilot Study of the Effectiveness of Intra-operative Ozurdex® in Vitrectomy Surgery for Epiretinal Membranes	N/A
Completed	`NCT01627977` - Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy	Phase 3
Completed	`NCT00408720` - Comparison of a Spectral OCT/SLO With the Stratus OCT for Imaging Various Retinal Pathologies	N/A
Completed	`NCT01771939` - Phacoemulsification and 25 Gauge (25G) Vitrectomy Versus Phacoemulsification Only in Idiopathic Epiretinal Membranes	N/A
Completed	`NCT05171621` - Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
Active, not recruiting	`NCT04306718` - Cultivation of Hyalocytes From ILM and ERM Samples: a Pilot Study	N/A
Recruiting	`NCT01985490` - Change in Foveal Avascular Zone After Removal of Epiretinal Membrane and Internal Limiting Membrane	N/A
Completed	`NCT01238393` - Treatment of Epiretinal Membranes With Ranibizumab	N/A
Terminated	`NCT00333060` - Study of OT-551 Eye Drops to Prevent or Delay Progression of Nuclear Cataracts Following Vitreous Removal	Phase 2
Completed	`NCT05287269` - Ocular Coherence Tomography During Cataract Assessment
Recruiting	`NCT05138315` - Quantification of Metamorphopsia in Patients With Epiretinal Membranes	N/A
Recruiting	`NCT03661593` - Aniseikonia in Epiretinal Membrane Patients	N/A
Completed	`NCT03457584` - Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling	N/A